Impact of the AGTR1 A1166C polymorphism on subcortical hyperintensities and cognition in healthy older adults

被引:0
作者
Lauren E. Salminen
Peter R. Schofield
Kerrie D. Pierce
Thomas E. Conturo
David F. Tate
Elizabeth M. Lane
Jodi M. Heaps
Jacob D. Bolzenius
Laurie M. Baker
Erbil Akbudak
Robert H. Paul
机构
[1] University of Missouri-Saint Louis,Department of Psychology
[2] Neuroscience Research Australia,School of Medical Sciences
[3] University of New South Wales,Mallinckrodt Institute of Radiology
[4] Washington University School of Medicine,undefined
[5] San Antonio Military Medical Center,undefined
[6] Vanderbilt University Medical Center,undefined
来源
AGE | 2014年 / 36卷
关键词
A1166C; Cerebrovascular aging; Subcortical hyperintensities; Cognition;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular aging consists of complex and multifaceted processes that may be influenced by genetic polymorphisms of the renin-angiotensin system. A polymorphism in the angiotensin II type 1 receptor gene (AGTR1/rs5186) has been associated with an increased risk for arterial stiffness, hypertension, and ischemic stroke. Despite these identified relationships, the impact of AGTR1 A1166C on white matter integrity and cognition is less clear in a healthy aging population. The present study utilized indices of neuroimaging and neuropsychological assessment to examine the impact of the A1166C polymorphism on subcortical hyperintensities (SH) and cognition in 49 healthy adults between ages 51–85. Using a dominant statistical model (CC + CA (risk) vs. AA), results revealed significantly larger SH volume for individuals with the C1166 variant (p < 0.05, partial eta2 = 0.117) compared with those with the AA genotype. Post hoc analyses indicated that increased SH volume in C allele carriers could not be explained by vascular factors such as pulse pressure or body mass index. In addition, cognitive performance did not differ significantly between groups and was not significantly associated with SH in this cohort. Results suggest that presence of the C1166 variant may serve as a biomarker of risk for suboptimal brain integrity in otherwise healthy older adults prior to changes in cognition.
引用
收藏
相关论文
共 227 条
  • [1] Ando H(2004)Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats Stroke 35 1726-1731
  • [2] Zhou J(2004)Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia J Int Neuropsychol Soc 10 442-452
  • [3] Macova M(2010)Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives Am J Hypertens 24 241-246
  • [4] Imboden H(2004)Longitudinal progression of subclinical structural brain disease in normal aging Am J Geriatr Psychiatr 12 190-200
  • [5] Saavedra JM(2011)Angiotensin peptides and central autonomic regulation Curr Opin Pharmacol 11 131-137
  • [6] Bigler ED(2003)Age-and education-corrected independent normative data for the RBANS in a community dwelling elderly sample Clin Neuropsychol 17 351-366
  • [7] Neeley ES(2006)Examining the repeatable battery for the assessment of neuropsychological status: factor analytic studies in an elderly sample Am J Geriatr Psych 14 976-979
  • [8] Miller MJ(2001)Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes Curr Opin Nephrol Hypertens 10 111-116
  • [9] Tate DF(2009)Mechanical properties of normal and diseased cerebrovascular system J Vasc Int Neurol 2 155-86
  • [10] Rice SA(2004)Repeatable battery for the assessment of neuropsychological status in a normal, geriatric sample Clin Gerontol 27 79-2713